Shopping Cart
- Remove All
- Your shopping cart is currently empty
PU139 is a novel inhibitor of histone acetyltransferase (HAT).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $56 | In Stock | |
5 mg | $122 | In Stock | |
10 mg | $213 | In Stock | |
25 mg | $463 | In Stock | |
50 mg | $668 | In Stock | |
100 mg | $932 | In Stock | |
500 mg | $1,860 | In Stock |
Description | PU139 is a novel inhibitor of histone acetyltransferase (HAT). |
Targets&IC50 | CBP:2.49 μM (IC50), GCN5:8.39 μM (IC50), PCAF:9.74 μM (IC50), p300:5.35 μM (IC50) |
In vitro | PU139 inhibits cell growth with GI50s of <60 μM (A431, A549, A2780, HCT116, HepG2, SW480, U-87 MG and SK-N-SH and MCF7 cells). PU139 (0-100 μM; 24-72 hours) triggers caspase-independent cell death in the neuroblastoma cell line SK-N-SH[1]. |
In vivo | PU139 (25 mg/kg; i.p.) enhances the growth-inhibitory effects of the chemotherapeutic agent Doxorubicin. |
Alias | PU-139, PU 139 |
Molecular Weight | 246.26 |
Formula | C12H7FN2OS |
Cas No. | 158093-65-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 1 mg/ml, Sonication is recommended. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.